Scientists today now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead our body and brain to decline as we age.
S-cubed is pleased to announce the launch of the A3 Community MDR provided free for the benefit of the CDISC user community. The A3 Community MDR allows users to browse and search the complete history of the CDISC Controlled Terminology.
Macadamian, together with Danish consortium partners Radiobotics and Bispebjerg Hospital, has been recognized by the Eurostars Network for driving innovation in the field of radiology.
- Market research insights from recent patient activation tests using the 83bar integrated digital health platform - Highlights from eight important medical categories, including depression, migraine, and NASH - Implications of findings for pharma...
Smarteeva announced the release if its Winter 2020 Smart Complaint System, which will have additional state-of-the-art enhancements to its Post Market Surveillance Suite.
Neurolixis Inc. has been awarded funds by the US Department of Defense to test its drug candidate, NLX-112, in a preclinical model of Machado-Joseph disease (MJD), a rare and disabling inherited movement disorder.
298 views, By Vitality in Aging (VIA) Research Group
New public benefit research organization, Vitality in Aging (VIA) Research Group, announces its launch with ground-breaking Longitudinal Study and Interventions Trial at RAADfest conference held at Westgate Las Vegas Resort & Casino, Las Vegas, Nevada.
World's Premier Bioeconomy Consulting Group Promotes Dr. Terry Mazanec, Vice Adm. Dennis McGinn (Ret.), Joel Stone, Glenn Farris, Dr. Doug Rivers and Tad Dritz, P.E
VALFIX Medical Inc. announces today an investment from California based angel group, Life Science Angels (LSA). This investment is part of the company's third investment round and concludes a meticulous due diligence process led by Dr.
CEO Coaching International, the leading firm for coaching growth-focused CEOs and entrepreneurs globally, announced today Philip Sullivan as its newest Partner and Coach.
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, has recently been...
Oncoheroes Biosciences Inc. ("Oncoheroes") and Boehringer Ingelheim International GmbH ("Boehringer Ingelheim") have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered..
- Expands patient activation into 8 more countries: Australia, Brazil, Canada, Colombia, Germany, Ireland, Mexico, and United Kingdom - 83bar is building on the US success of its fully integrated digital health technology and concierge platform - Will...
On June 21, 2019, CEN Biotech, Inc. (CEN) entered into a Merger Agreement (the "Merger Agreement") with Caduceus Software Systems Corp., a Wyoming corporation ("CSOC") and Caduceus Merger Sub, Inc., a Wyoming corporation and a wholly owned subsidiary of..
Innovative open source software, originally developed for public health, is freely available to EHR and PHR systems to support clinical decision support for immunizations.
Scientists today now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead our body and brain to decline as we age.
S-cubed is pleased to announce the launch of the A3 Community MDR provided free for the benefit of the CDISC user community. The A3 Community MDR allows users to browse and search the complete history of the CDISC Controlled Terminology.
Macadamian, together with Danish consortium partners Radiobotics and Bispebjerg Hospital, has been recognized by the Eurostars Network for driving innovation in the field of radiology.
- Market research insights from recent patient activation tests using the 83bar integrated digital health platform - Highlights from eight important medical categories, including depression, migraine, and NASH - Implications of findings for pharma...
Smarteeva announced the release if its Winter 2020 Smart Complaint System, which will have additional state-of-the-art enhancements to its Post Market Surveillance Suite.
SciTech Development, a clinical stage drug development company, is pleased to announce that it will be presenting a poster at the 61st Annual American Society of Hematology (ASH) Meeting & Exposition in Orlando, Florida, December 7-10.
Neurolixis Inc. has been awarded funds by the US Department of Defense to test its drug candidate, NLX-112, in a preclinical model of Machado-Joseph disease (MJD), a rare and disabling inherited movement disorder.
298 views, By Vitality in Aging (VIA) Research Group
New public benefit research organization, Vitality in Aging (VIA) Research Group, announces its launch with ground-breaking Longitudinal Study and Interventions Trial at RAADfest conference held at Westgate Las Vegas Resort & Casino, Las Vegas, Nevada.
IRAK signalling is crucial for protective immunity against specific bacteria. Threonine345 is the main prototypical phosphoresidue required for the activity of IRAK4. AbboMax offers anti-IRAK4(pT345) antibody
World's Premier Bioeconomy Consulting Group Promotes Dr. Terry Mazanec, Vice Adm. Dennis McGinn (Ret.), Joel Stone, Glenn Farris, Dr. Doug Rivers and Tad Dritz, P.E
VALFIX Medical Inc. announces today an investment from California based angel group, Life Science Angels (LSA). This investment is part of the company's third investment round and concludes a meticulous due diligence process led by Dr.
CEO Coaching International, the leading firm for coaching growth-focused CEOs and entrepreneurs globally, announced today Philip Sullivan as its newest Partner and Coach.
Re-Stem Biotech (Re-Stem or the Company), a biotechnology firm engaged in the research and development of cell based therapies and products for various indications, including osteoarthritis, stroke, spinal cord injury and cancer, has recently been...
It is with great pleasure that Light4Soul, the creative agency hosting the MedTech Visionaries Awards announced that Peter McCredie has signed on as a judge for this prestigious event. Peter is managing director of EarthCom.
Berea BioVentures will be collaborating with Yokohama-based CMPlus Corporation in their efforts to match US and Japanese life science companies with industry experts from both countries.
Highlights include the unique ability of CR13626 to enter the brain, to selectively inhibit multiple tyrosine kinases (EGFR, VEGFR2, FYN, YES) that fuel tumour growth, and to increase survival in a mouse model of glioblastoma
Oncoheroes Biosciences Inc. ("Oncoheroes") and Boehringer Ingelheim International GmbH ("Boehringer Ingelheim") have signed a worldwide, exclusive licensing agreement for volasertib, an investigational anti-cancer compound that was originally discovered..
- Expands patient activation into 8 more countries: Australia, Brazil, Canada, Colombia, Germany, Ireland, Mexico, and United Kingdom - 83bar is building on the US success of its fully integrated digital health technology and concierge platform - Will...
